How Much Is The Agnew Clinic Worth?
Last updated: April 24, 2026
Quick Facts
- Methodology
- comparable analysis
The Agnew Clinic (1889) is a museum-held, canonical Eakins masterpiece and is effectively off the open market. If legally and institutionally saleable, a conservative market estimate for a realistic open‑market realization is $20–40 million; a private/consortium institutional sale could push well above that range but is a low-probability outcome.
Valuation Analysis
Bottom line: The Agnew Clinic (1889) by Thomas Eakins is an institutional masterpiece and, under current custodial conditions, effectively off the open market. If, hypothetically, clear title and deaccession authority were obtained and the painting were placed into an open market process, a conservative market range for a likely realization is approximately $20–40 million. Under exceptional circumstances (a motivated institutional consortium or extraordinary private buyer), realized pricing could be materially higher. [1][2]
The painting has been retained by the University of Pennsylvania since its commission and is normally on renewable loan to the Philadelphia Museum of Art; there is no public auction sale record for this canvas and no publicly disclosed insurance appraisal. Institutional ownership, probable gift/deed terms, and museum deaccession rules create significant legal, governance and reputational barriers to sale that meaningfully reduce liquidity and increase execution risk. [1]
A direct market precedent for large Eakins medical canvases is the 2006 reported consortium handling of The Gross Clinic (widely reported at $68 million). That transaction was exceptional: it was resolved by institutional negotiation and local public matching efforts, and it demonstrates the ceiling that a museum-quality Eakins can achieve when institutions and civic interests align. It is a high‑end precedent but not a routine market comparator. [2]
By contrast, public-auction evidence for Eakins canvases is sparse and shows substantially lower open‑market ceilings: large autograph canvases have rarely appeared publicly and when they do top realized auction results have historically been in the single- to low‑multi‑millions, while studies and works on paper trade in the low‑to‑mid five figures. This divergence reflects a constrained buyer pool (primarily museums and very deep‑pocketed collectors) and the strong effect of institutional custody on liquidity. [3]
Given these inputs, the $20–40 million range reflects a pragmatic balance: it prices in The Agnew Clinic's rarity, size and historical importance while applying a discount for the realistic legal/governance and reputational barriers to sale that will deter many bidders or force a private/consortium route. If title and donor restrictions were cleared and a competitive institutional buyer set emerged, a private sale could approach (but is unlikely to exceed) the exceptional Gross Clinic ceiling without extraordinary market interest; conversely, a contested public sale would likely depress realizable value.
Next steps: obtain the University of Pennsylvania accession/deed documents and any donor/gift restrictions, secure a current conservation/condition report, and engage Christie’s/Sotheby’s American Art specialists for confidential market checks. With those items a formal appraisal or a targeted private‑sale strategy can be prepared.
Key Valuation Factors
Art Historical Significance
High ImpactThe Agnew Clinic is a major late‑19th‑century clinical/narrative canvas by Thomas Eakins and is widely cited in scholarship on medical subject matter, realism, and American academic painting. Its compositional scale, documentary depiction of surgical practice, and identifiable sitters make it a canonical work in both museum and academic contexts. This weight of art‑historical importance normally supports a substantial premium relative to routine portraits or studies because institutions prize such works for exhibitions and scholarship. Paradoxically, that very significance reduces liquidity: museums and donors are reluctant to permit canonical works to leave public collections, which constrains the pool of willing buyers and channels any sale into specialized private or institutional transactions.
Provenance & Legal Restrictions
High ImpactThe University of Pennsylvania’s continuous ownership since commission (and the painting’s loan arrangements) imply probable donor/commission clauses, accession records and institutional deaccession policies that must be resolved before any legal sale. Gift‑deed covenants, state or institutional regulations and public interest in Philadelphia cultural patrimony all create substantive procedural, legal and reputational hurdles. These factors materially lower the probability of a clean, competitive open‑market sale and therefore impose a practical discount on market value unless clear legal authority and an acceptable sale pathway (often a negotiated institutional consortium) are established.
Comparables & Market Liquidity
High ImpactMarket comparables are bifurcated: the Gross Clinic’s 2006 reported consortium handling (~$68M reported) shows a high institutional ceiling when civic and museum actors align, while recorded public-auction results for large Eakins canvases are far lower (single‑ to low‑multi‑millions). Small Eakins works and studies trade at much lower levels. The limited frequency of high‑quality Eakins canvases reaching market concentrates buyer power among institutions and ultra‑high‑net‑worth collectors, making sale outcomes highly channel‑dependent. This creates a wide potential range but a realistic mid‑market expectation after applying liquidity and governance discounts.
Condition, Exhibition & Publication History
Medium ImpactA stable conservation record and robust exhibition/publication history enhance market value because they reduce technical uncertainty and signal institutional validation. The Agnew Clinic has been widely exhibited and published, which supports demand. However, I do not have a current conservation/condition report; any significant restoration needs or structural problems would materially reduce value and could complicate sale logistics and insurance. Confirming condition and recent treatment history is therefore necessary to refine and finalize valuation.
Sale History
The Agnew Clinic has never been sold at public auction.
Thomas Eakins's Market
Thomas Eakins is one of the most important American realists of the late 19th century and his major canvases are concentrated in museum collections, which makes high‑quality autograph works scarce on the open market. Public auction activity for Eakins tends to be limited to studies, photographs and occasional portraits; the few large institutional or private transactions (notably the Gross Clinic episode) show strong willingness by museums and consortia to pay premium sums for canonical works. Consequently, Eakins’ market is characterized by scarcity, institutional demand and channel sensitivity — top values are achievable but infrequently realized.
Comparable Sales
The Gross Clinic
Thomas Eakins
Same artist; large-scale, narrative/medical operating-room scene and the clearest market precedent for a museum-grade Eakins canvas; shows private/consortium demand and the potential top-of-market ceiling for Eakins' major canvases.
$68.0M
2006, Private / institutional consortium (reported, Philadelphia match)
~$106.2M adjusted
Cowboys in the Badlands
Thomas Eakins
Same artist; one of the largest public auction realizations for an Eakins canvas in the modern record — useful as a public-auction high for market-available Eakins works and to show gap between open-market and private/consortium outcomes.
$5.4M
2003, Christie's New York (auction)
~$9.2M adjusted
Cattleya Orchid with Two Brazilian Hummingbirds
Martin Johnson Heade
High-quality 19th‑century American painting sold at auction; not by Eakins but a relevant period/marketability comparable to gauge demand and price bands for museum-quality late‑19th‑century American works.
$3.4M
2024, Christie's (19th‑Century American & Western Art sale)
~$3.4M adjusted
The Singer (Mrs. Liego)
Thomas Eakins
Recent auction sale of an Eakins oil of modest scale; illustrates the lower end of realised prices for works by Eakins that do appear on the open market (studies/portraits), and helps bracket liquidity vs. institutional masterpieces.
$38K
2024, Doyle (New York) auction
~$39K adjusted
Current Market Trends
The market for museum‑quality 19th‑century American realism remains selective: demand is steady for canonical works but overall auction liquidity and top‑end activity softened in 2023–24. That environment favors conservatively priced, well‑documented works and makes blockbuster public auctions less common. For a work like The Agnew Clinic, scarcity and exhibition pedigree matter more than short‑term market cycles, but legal and reputational constraints are the decisive determinants of realizable price.
Sources
- University of Pennsylvania Archives — The Agnew Clinic (ownership and presentation history)
- Washington Post — Philadelphia blocks sale of Eakins painting by matching $68 million bid (2006 Gross Clinic coverage)
- MutualArt — Thomas Eakins auction records and sale history (representative market data)
- Philadelphia Museum of Art — Gross Clinic exhibition and related materials